Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 10,888 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aclarion Inc | ACON | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0148 | -4.56% | 0.31 | 07:36:41 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.3248 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 14 | 10,888 | - | 0.2668 - 25.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 07:36:41 | formt | 100 | US$ 0.31 | USD |
Aclarion Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 175.86k | 549.56k | - | 75k | -4.91M | -8.94 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aclarion News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACON Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3077 | 0.349399 | 0.3001 | 0.3277041 | 455,931 | 0.0023 | 0.75% |
| 1 Month | 0.2955 | 0.355 | 0.2706 | 0.3083307 | 451,495 | 0.0145 | 4.91% |
| 3 Months | 0.36 | 0.69 | 0.2706 | 0.3817301 | 2,734,872 | -0.05 | -13.89% |
| 6 Months | 4.2096 | 7.3984 | 0.2668 | 2.07 | 2,688,201 | -3.90 | -92.64% |
| 1 Year | 23.84 | 25.60 | 0.2668 | 5.15 | 1,684,599 | -23.53 | -98.70% |
| 3 Years | 46.40 | 64.80 | 0.2668 | 11.18 | 1,146,207 | -46.09 | -99.33% |
| 5 Years | 46.40 | 64.80 | 0.2668 | 11.18 | 1,146,207 | -46.09 | -99.33% |
Aclarion Description
| Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. |
